Molecular dynamics and physical stability of ibuprofen in binary mixtures with an acetylated derivative of maltose by Grzybowska, Katarzyna et al.
Molecular Dynamics and Physical Stability of Ibuprofen in Binary
Mixtures with an Acetylated Derivative of Maltose
Katarzyna Grzybowska,* Andrzej Grzybowski, Justyna Knapik-Kowalczuk, Krzysztof Chmiel,
Krzysztof Woyna-Orlewicz, Joanna Szafraniec-Szczęsny, Agata Antosik-Rogoź,̇ Renata Jachowicz,
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ABSTRACT: In this paper, we explore the strategy increasingly used to
improve the bioavailability of poorly water-soluble crystalline drugs by
formulating their amorphous solid dispersions. We focus on the potential
application of a low molecular weight excipient octaacetyl-maltose (acMAL) to
prepare physically stable amorphous solid dispersions with ibuprofen (IBU)
aimed at enhancing water solubility of the drug compared to that of its
crystalline counterpart. We thoroughly investigate global and local molecular
dynamics, thermal properties, and physical stability of the IBU+acMAL binary
systems by using broadband dielectric spectroscopy and differential scanning
calorimetry as well as test their water solubility and dissolution rate. The
obtained results are extensively discussed by analyzing several factors
considered to affect the physical stability of amorphous systems, including
those related to the global mobility, such as plasticization/antiplasticization effects, the activation energy, fragility parameter, and the
number of dynamically correlated molecules as well as specific intermolecular interactions like hydrogen bonds, supporting the latter
by density functional theory calculations. The observations made for the IBU+acMAL binary systems and drawn recommendations
give a better insight into our understanding of molecular mechanisms governing the physical stability of amorphous solid dispersions.
KEYWORDS: ibuprofen, amorphous drug, amorphous solid dispersion, molecular dynamics, glass transition, crystallization, devitrification,
physical stability
■ INTRODUCTION
Many pharmaceutical compounds in the crystalline state are
thermodynamically stable materials; their properties are well-
defined, but they often have a low water solubility, leading to
low dissolution rate and bioavailability. One of many popular
drugs, the crystalline form of which is practically insoluble in
water, is ibuprofen (IBU). Ibuprofen is a nonsteroidal anti-
inflammatory drug commonly used to reduce fever, pain, and
stiffness. According to the Biopharmaceutical Classification
System (BCS), IBU has been classified as a class II drug, which
means that it has a poor solubility despite the good
permeability.1 Thus, the low oral bioavailability of IBU is
due to its solubility and dissolution rate limitations.2 Such
properties for a painkiller are unfavorable because the fastest
possible dissolution rate of an analgesic drug associated with its
rapid onset of action is essential in the case of pain situations
(particularly in rheumatoid, osteoarthritis, or dental pain).
Considering the widespread use of IBU, the improvement of
water solubility and the dissolution rate of the drug is a rational
and ambitious challenge.
Transformation of the crystalline form of a drug into a less
ordered amorphous structure is one of the key formulation
technologies in the pharmaceutical industry because amor-
phous solids are usually characterized by higher solubility and
higher dissolution rate than corresponding crystals.3−12
Despite the obvious useful properties of amorphous drugs, so
far, only a few oral amorphous formulations have been
available on the market because of various problems. One of
the most unfavorable aspects of the amorphous formulations is
their poor physical stability due to higher internal energy and
specific volume of the amorphous state relative to the
crystalline state.13 The molecular mobility is generally
considered as a key attribute that determines the physical
stability of the amorphous drugs.14−16 A relatively high
molecular mobility in glassy systems can lead to faster phase
separation, drug nucleation, and crystal growth. Consequently,
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amorphous drugs may spontaneously convert back to
crystalline forms during production, storage, and use of the
product, losing the desired properties associated with the
disordered structure of the glasses.
In recent years, many efforts have been put into finding
effective methods for improving the physical stability of
amorphous pharmaceuticals. A promising way to reduce the
tendency of amorphous drugs to crystallize and enhance their
water solubility by formulating it as amorphous solid
dispersions with certain excipients, including polymers
(polymeric amorphous solid dispersion)17 and low molecular
weight compounds such as saccharides,18 amino sugars,19
acetated saccharides,10,20−22 urea,23 amino acids,24 organic
acids,25 or other drugs (coamorphous solid dispersions).26,27
The tendency of the drug to crystallize may be reduced in
amorphous solid dispersions mainly by interplaying two
factors:28−30 (i) specific intermolecular interactions between
molecules of drug and excipient or/and (ii) slowing down the
global molecular mobility in the mixture associated with the
structural relaxation or/and local molecular motion linked to
secondary relaxations.
Decreasing the global molecular mobility may be achieved
by mixing an amorphous drug that has a low glass transition
temperature Tg with a high Tg compound (usually with
polymers). In such a binary mixture, a high Tg excipient is an
antiplasticizer of a drug; that is, it causes an increase in Tg of
the binary mixture (drug−excipient) compared with Tg of pure
API. The increase in Tg of the binary composition is associated
with a decrease in the mobility of whole molecules of a
pharmaceutical and, consequently, with a reduction in the
tendency to the drug crystallization in the glassy solution.
However, the antiplasticization is not always sufficient to
completely suppress the recrystallization,31,20 and for some
drugs, crystallization can be completely inhibited without any
antiplasticizing effect.20 The mechanism of crystallization
inhibition in such cases is mainly related to the specific
intermolecular interactions between drug and excipient, such
as hydrogen bonds or ionic interactions. Molecules of an
excipient, which are able to specifically interact with the drug
molecules, prevent the recrystallization process of the
drug.10,31−33,22
In this context, the amorphous solid dispersions of drugs
with the use of an acetylated derivative of sugars as
crystallization inhibitors are very interesting. Grzybowska and
co-workers10 were the first to use small molecular weight
octaacetylmaltose (acMAL) to effectively inhibit celecoxib
(CEL) crystallization in the binary glassy solution (CEL
+acMAL). They found that even a small content (10%) of
acMAL in the solution completely counteracts the recrystal-
lization of the glassy state. In this system, the antiplasticization
effect does not play any role in this way of physical stabilization
of amorphous CEL because the values of Tg of both
compounds (drug and excipient) are the same (Tg = 331 K).
Indeed, no increase in Tg of the amorphous binary systems was
found due to the addition of acMAL to the drug, and even the
values of Tg for the CEL-acMAL glassy solution were slightly
lower than that for pure celecoxib. Whereas, the stabilizing
effect of acMAL on the CEL has been correlated with the
slowing down of local molecular movements in the binary
glassy solution (CEL+acMAL) reflected in the dielectric
secondary (β- and γ-) relaxations. It has been established
that significant suppression of local mobility of glassy CEL in
the acMAL matrix reflected in both the intermolecular (β-
process) and intramolecular (γ-process) is a result of strong
hydrogen bonds formed between CEL and the CO group
of acMAL. Moreover, the application of acMAL significantly
enhanced not only the physical stability but also the water
solubility of CEL in the binary glassy solutions (CEL
+acMAL). The water solubility of pure amorphous CEL was
only 1.5 times better than its crystalline counterpart, whereas
the water solubility of the amorphous CEL systems containing
10 and 30 wt % of acMAL was, respectively, 6 and 12 times
greater than that for the crystalline drug. The pioneering
application of acMAL to effectively stabilize amorphous CEL
and also to improve its water solubility has inspired further
successful attempts21,22 at exploiting acetylated saccharides as
crystallization inhibitors of other amorphous pharmaceuticals.
Kaminska et al. have shown that acMAL might be very
effective in stabilizing the amorphous form of indomethacin
(IMC).22 The authors found that strong interactions between
the IMC and acMAL by forming hydrogen bonds between
molecules of both compounds led to the improvement in the
physical stability of amorphous API even at temperatures
higher than Tg of the binary systems. The water solubility of
amorphous IMC was also enhanced in solid dispersions with
acMAL. Another study also proved the stabilizing effect of
different acetylated saccharides, such as acetylated maltose,
sucrose, glucose, and galactose on nifedipine (NIF) in the
binary glassy solutions.21 It has been found that hydrogen
bonds between NIF and acetated disaccharides are stronger
than H-bonds interactions between NIF and acetated
monosaccharides. It has been correlated with a higher
crystallization barrier for crystallization binary solid dispersion
of NIF with acetated disaccharides and, consequently, with
better stabilization of the drug in such binary systems both
above and below the glass transition temperature. Acetylated
sugars like maltose, sucrose, and glucose have also been used to
increase the chemical stability of furosemide,34 which easily
degraded as a neat drug upon melting or cryogenic grinding.
Theoretical computations have indicated that H-bonds play an
important role in the destabilization mechanism of furosemide
upon milling. Kaminska et al. shown that acylated saccharides
like maltose, sucrose, and glucose inhibit the chemical
decomposition of furosemide during the cryomilling of the
binary mixtures. This effect was attributed to the reduction in
H-bonds formation between the API and the modified
carbohydrates. Moreover, furosemide cryomilled with acylated
glucose, acylated maltose, and acylated sucrose is much more
soluble with respect to the crystalline form of this active
pharmaceutical ingredient (API).34
In this work, we investigate the effects of adding low
molecular weight octaacetyl-maltose (acMAL) on the molec-
ular dynamics, thermal properties, and the physical stability of
ibuprofen (IBU) in the binary mixtures (IBU+acMAL).
Although acMAL has a low molecular weight, its glass
transition temperature Tg is much higher than that for IBU.
Thus, one can suppose that the excipient will be a good
antiplasticizer of IBU. By using the broadband dielectric
spectroscopy and differential scanning calorimetry, we check
the role of the antiplasticization effect of acMAL on the drug as
well as other molecular and thermodynamic factors on the
enhancement of the physical stability of IBU in binary mixtures
(IBU+acMAL). Exploiting theoretical calculations within the
framework of the density functional theory (DFT), we study
specific interactions between molecules of both compounds in
the binary mixtures (IBU-acMAL) and their potential role in
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crystallization inhibition of IBU by acMAL. Finally, we
examine whether the excipient acMAL in the binary mixtures
(IBU-acMAL) improves the water solubility of the drug. Such
studies are essential for the evaluation of acMAL as a potential
excipient for manufacturing solid dosage forms of IBU of
improved bioavailability.
■ EXPERIMENTAL METHODS
Materials. The crystalline form of ibuprofen (IBU) of the
molecular mass of 206.28 g/mol and 98% purity was supplied
from Sigma-Aldrich. β-D-Maltose octaacetate (acMAL) of a
molecular mass of 678.59 g/mol was supplied from Iris Biotech
GMBH (Germany) in the crystalline form. Chemical
structures of the examined materials are presented in Chart 1.
Method of Preparation of Amorphous Solid Dis-
persions IBU with acMAL. The amorphous binary systems
IBU+acMAL with different amounts of excipient (acMAL)
were prepared by a quench-cooling of the molten phase of the
binary mixtures. Before preparing the binary mixtures of IBU
+acMAL with a small content of acMAL (≤30 wt % of
acMAL), the pure crystalline acMAL was vitrified and
powdered at room temperature, whereas the pure crystalline
ibuprofen was heated slightly above its melting point (up to 95
°C) on the heating plate. Next, a sufficient amount of
powdered amorphous acMAL was added to the molten
ibuprofen and intensively mixed until a homogeneous binary
mixture was obtained. For larger content of acMAL (≥30 wt
%), the mixture became supersaturated and crystallized during
the maltose dissolving procedure in liquid ibuprofen. To obtain
the binary mixtures (IBU+acMAL) with a larger content of
acMAL, the drug in the crystalline form had to be dissolved in
the molten phase of acMAL.
Broadband Dielectric Spectroscopy Measurements
(BDS). Isobaric measurements of the dielectric permittivity
ε*(ω) = ε′(ω) − i′′(ω) were performed using the
Novocontrol Alpha dielectric spectrometer over a frequency
range (10−2−106 Hz ) and a temperature range (120−320 K)
at ambient pressure. Nonisothermal and isothermal dielectric
measurements of IBU+acMAL mixtures were performed in a
parallel-plate cell immediately after preparing the amorphous
sample. The sample temperatures were controlled by the
Quatro System using a nitrogen gas cryostat. The temperature
stability was better than 0.1 K. To confirm the repeatability of
measurements, each measurement was repeated three times for
newly prepared samples.
Differential Scanning Calorimetry (DSC). Calorimetric
measurements of the investigated binary mixtures were carried
out by the Mettler-Toledo DSC apparatus equipped with a
liquid nitrogen cooling accessory and an HSS8 ceramic sensor
(heat flux sensor with 120 thermocouples). Temperature and
enthalpy calibrations were performed by using indium and zinc
standards. Each measurement at the given heating rate was
repeated 3 times. For each experiment, a new amorphous
sample was prepared.
To obtain the accurate temperature dependences of heat
capacity Cp(T) for examined mixtures and temperature
dependences of calorimetric structural relaxation times for
binary mixtures of IBU+acMAL, a stochastic temperature-
modulated differential scanning calorimetry (TMDSC)
technique implemented by Mettler-Toledo TOPEM has been
exploited. The samples were heated at a rate of 0.5 K/min. In
the experiment, the temperature amplitude of the pulses of 0.5
K was selected. To achieve a higher accuracy of the heat
capacity, we adjusted our evaluations using a sapphire
reference curve. The glass transition temperature Tg was
determined as the temperature of the half step height of the
temperature dependences of the quasi-static heat capacity
Cp(T).
Computational (DFT). Theoretical studies were per-
formed within the framework of the density functional theory.
DFT calculations have been done using the B3LYP35−37
functional and def2-TZVP basis set.38 The environment of
molecular systems was taken into account by applying the
PCM continuum solvation model39,40 with dielectric constant
ε = 2.5. The molecular structures of the IBU and acMAL
monomers, IBU homodimer, and IBU+acMAL complex were
fully optimized without any constraints at the DFT level of
theory. Grimme’s D3 dispersion correction for a density
functional41 was applied in order to include intramolecular and
intermolecular dispersion interactions. The association energy
for IBU homodimer and IBU-acMAL heterodimer has been
estimated using the supermolecular approach. For IBU, to
obtain the potential energy curve (PEC) and dipole moments
as a function of the selected rotation coordinate, the single-
point calculations were performed for four selected torsion
angles (see Figure 12) in a range from 0 to 360 with a step size
of 10 degrees. In each point, corresponding torsion coordinates
in the molecular structure were frozen and excluded from
optimization, and at once, the remaining geometrical
parameters were relaxed. All calculations were performed
using Gaussian 09 quantum-chemical software.42
Solubility Test. The solubility studies were performed in
purified water for binary mixtures of IBU with the large
content of acMAL (IBU+83 wt % acMAL, IBU+86 wt %
Chart 1. Chemical Structures of Investigated Compounds
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acMAL, and IBU+87.5 wt % acMAL). Each study was
performed in 50 mL Erlenmeyer flasks. An excess of drug or
binary system was dispersed in 25 mL of the solvent. The
suspension was shaken at room temperature using the KS 130
Basic shaker (IKA, Germany) for at least 24 h to achieve the
equilibrium solubility. Samples were centrifuged at 3600 rpm
for 30 min in the MPW 221 apparatus (MPW, Poland) and
filtered through a 0.2 μm membrane filter. The samples were
assayed at 221 nm with the UV−vis spectrophotometer V-500
(Shimazu UV1800, Japan). The reported data represents the
averages from three measurements.
Dissolution Studies. The IBU release profile was tested in
the Hanson Research SR8PLUS dissolution station combined
with Dissoette II Autosampler and spectrophotometer UV/vis
Jasco V530 for binary mixtures of IBU with the large content
of acMAL (IBU+83 wt % acMAL, IBU+86 wt % acMAL, and
IBU+87.5 wt % acMAL). The studies were performed in
Ph.Eur. app.2 at 50 rpm. The tested samples containing 50 mg
of IB were poured into vessels filled with 900 mL of purified
water preheated up to 37 ± 0.5 °C. The IBU concentration
was determined spectrophotometrically at 221 nm.
■ RESULTS AND DISCUSSION
To determine the thermal properties of pure compounds (IBU
and acMAL) used to prepare binary mixtures, the standard
calorimetric measurements by means of differential scanning
calorimetry (DSC) have been performed (see Figure 1). IBU
has a low melting temperature, Tm = 76 °C, and a low glass
transition temperature, Tg = −46 °C. Due to that, IBU after
vitrification is not an amorphous solid at ambient temper-
atures, but it is a viscous, supercooled liquid. Therefore, under
normal conditions, IBU cannot be prepared as an amorphous
oral solid dosage form (tablets) without using appropriate
excipients. Octaacetylmaltose (acMAL) is characterized by a
much higher Tg (=60 °C) than that for IBU. Mixing of two
compounds characterized by different glass transition temper-
atures typically results in a higher Tg of the binary mixture
(drug−excipient) compared to Tg of pure API if the low Tg
compound is the API. Thus, we may suppose that acMAL will
be a good antiplasticizer of IBU and significantly increase Tg of
the binary composition (IB+acMAL) from that of the pure
drug to obtain the amorphous solid dispersion characterized by
the high physical stability in ambient conditions.
Molecular Dynamics of Binary Mixtures (IBU+acMAL).
Relaxation Processes at T > Tg. The broadband dielectric
spectroscopy (BDS) measurements of pure compounds (IBU
and acMAL), as well as their binary mixtures with different
content (5, 10, 20, and 30 wt %) of acMAL, have been
performed to check how a gradual adding acMAL to IBU
affects the molecular mobility of IBU and, consequently, its
stability in the wide temperature range. Representative
dielectric loss spectra for investigated systems measured at
different temperatures during heating of the samples from the
glassy to the liquid state are presented in Figure 2.
It is clearly seen that the dielectric spectra for the
supercooled liquid state of the examined mixtures (IBU
+acMAL) are more complex in comparison with spectra of
most glass-forming liquids, for which usually only a single
relaxation process (i.e., structural α-relaxation) with a large
magnitude is observed at T > Tg. In the case of IBU+acMAL
mixtures, above their Tg, we can distinguish two well-resolved
relaxation processes with relatively large amplitudes. Based on
TMDSC measurements (the results of which will be shown
later), we identify the faster dielectric process as a structural α-
relaxation of the mixtures, associated with the glass transition
of the investigated binary systems. The peculiar dielectric
process, slower than the α-relaxation, has been called by us as
an s-process. We noticed that the amplitude of the s-process
strongly depends on the content of acMAL in the mixture in
comparison with α-relaxation. This finding is clearly seen in
Figure 3, in which the representative dielectric spectra are
collected for pure IBU as well as for its binary mixtures with
different content of acMAL measured at the same temperature
(T = 259 K > Tg). If the content of acMAL in the mixture is
low, the amplitude of the s-process is much smaller than that
for the α-process. The gradual addition of acMAL to IBU
results in an increase in dielectric strength Δεs of s-process. If
the amount of acMAL in the mixture reaches ∼20 wt %, the
amplitudes of both processes (Δεα and Δεs) become
comparable (see a representative example in the inset to
Figure 3). The spectacular increase in the dielectric strength
Δεs of the s-relaxation process with increasing acMAL content
in the mixture suggests that the s-relaxation reflects mainly the
acMAL dynamics in the (IBU+acMAL) mixture.
Two relaxation processes detected in dielectric spectra above
Tg may suggest inhomogeneity of the binary systems and
microphase separation.43,22 Therefore, it is necessary to verify
whether the investigated binary mixtures IBU+acMAL are
homogeneous, and the s-process observed above Tg is not a
result of some phase separations of IBU and acMAL. Exploring
this issue, we have not observed any visual signs of phase
separation in the examined mixtures. Moreover, we checked
whether the dielectric spectrum of the freshly prepared sample
of the binary mixture IBU+10 wt % acMAL changes with the
time of the sample storage at a given temperature. As can be
seen in Figure 4, the dielectric spectrum of the mixture with 10
wt % of acMAL does not change even after 9 h of the sample
storage at T = 247 K. This result shows that there are no
changes in both the α- and s-relaxations, and consequently,
there is no phase separation in the binary mixtures IBU
+acMAL at least during the time-dependent dielectric
Figure 1. DSC thermograms of the pure IBU and acMAL obtained
during heating (10 K/min), their crystalline and amorphous forms.
The first run was performed for crystalline samples (dashed lines),
whereas the second one for amorphous samples (solid lines) was
obtained by cooling the fully melted crystals below the glass transition
temperatures Tg (vitrification).
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experiment. This conclusion is also supported by other
experimental observations: (i) dielectric measurements are
repeatable for each newly prepared sample of a binary mixture;
(ii) in DSC thermograms obtained for each investigated binary
mixtures, we observed only a single glass transition (Tg sof IBU
and acMAL differ significantly, ΔTg = 106 K, and therefore, in
the case of phase separation one may observe two well-
distinguished glass transitions for each compound in DSC
thermograms). It is worth noting that a previous study of water
mixtures with some propylene glycol oligomers leads to the
conclusion that the occurrence of two relaxation peaks in
dielectric spectra above Tg of the binary systems does not
always have to mean the system inhomogeneity and micro-
phase separation. For those binary systems (i.e., tripropylene
glycol+H2O and PPG 400+H2O), the components of which
are characterized by excellent miscibility, also two well-
distinguished relaxation peaks with large amplitudes were
observed: the slower one was the α-relaxation associated with
the glass transition of the binary system, whereas the faster one
reflected the molecular dynamics of water molecules in the
Figure 2. Dielectric loss spectra for pure IBU (a) and for its binary
mixtures with 5 wt % (b), 10 wt % (c), 20 wt % (d), and 30 wt % (e)
of acMAL at several temperatures.
Figure 3. Dielectric loss spectra for pure IBU and for its binary
mixtures with 5, 10, and 20 wt % of acMAL obtained at the same
temperature, T = 259 K. The inset shows the dependence of the
dielectric strength of the α- and s-processes vs content of acMAL in
the binary mixtures (IBU+acMAL) at T = 259 K.
Figure 4. Dielectric loss spectra for a mixture of IBU+10 wt % acMAL
obtained immediately after sample preparation at T = 247 K (black
points) and after 9 h of its storage at the same temperature (red
points).
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mixtures.44,45 Another interesting example of the relaxation
spectra involving two segmental processes of comparable
amplitudes have been recently reported by Vagelis et al. for
perfectly miscible binary blends of polystyrene with oligostyr-
ene.46
It is very interesting that the broad and symmetric s-process
in the binary mixtures (IBU+acMAL) occurs in a similar
frequency range in which the Debye relaxation (D-process) is
observed in pure IBU (see Figure 2). The molecular origin of
the D-process observed in pure IBU has already been widely
discussed.47−51 Pure IBU has a big tendency to form H-
bonded aggregates such as dimers and trimers (linear and
cyclic), and the molecular origin of this process has been
related to H-bonds dynamics. Correia and Affuard showed that
the D-process in pure IBU is dominated by the cis- to trans-
transformation of the carboxyl group (OCOH) in IBU
coupled to H-bonds dynamics.50 Recently, Adrjanowicz and
co-workers have established that the D-process can be also
observed in methylated IBU, which cannot form H-bonds. It
has been related to the analogous transformation of a
methylated carboxyl group from the synperiplanar to the
antiperiplanar conformation.51 However, the amplitude of the
process in Me-IBU is considerably smaller than that in normal
IBU, which indicates that H-bonds strongly affect the D-
process in nonmethylated IBU. By using MD simulations,
Correia and Affuard found that although the synperiplanar to
the antiperiplanar transformation of carboxyl groups in the H-
bonded aggregates of IBU molecules is promoted by linear
(single) H-bonds between IBU molecules, this transformation
is hindered by cyclic (double) H-bonds between the OC
OH groups of IBU molecules.50 Thus, the character of H-
bonds formed between the same molecular species (IBU···
IBU) and the different ones (IBU···acMAL) could be a hint on
the occurrence of the D-process originated from the
synperiplanar to the antiperiplanar transformation of carboxyl
groups in IBU molecules in the IBU+acMAL mixtures. To gain
a better insight into the properties of H-bonds that enable to
form homodimers (IBU···IBU) and heterodimers (IBU···
acMAL), we have performed calculations based on the density
functional theory (DFT), details of which are described later in
the paper. As a result, we have determined that the cyclic H-
bonds between IBU and acMAL are stronger than those
formed between two IBU molecules (see Figure 5). This
conclusion can be drawn from the larger association energy of
the heterodimer IBU···acMAL (ΔEass (IBU···acMAL) = 73.4
kJ/mol) than that of the homodimer IBU···IBU (ΔEass (IBU···
IBU) = 66.6 kJ/mol). It suggests that the cyclic heterodimers
IBU···acMAL may be easier formed than the cyclic
homodimers IBU···IBU. Taking into account the results of
DFT calculations as well as the observed position of s-process
and the increase in its amplitude with increasing acMAL
content (see Figure 3) in the case of the investigated binary
mixtures, we suppose another effect of the cyclic H-bonds
between different species, acMAL, and IBU molecules than
those between IBU molecules on the synperiplanar to the
antiperiplanar transformation of carboxyl groups in IBU
molecules. It seems that the heterocyclic H-bonds may
promote this transformation, which can be reflected in the s-
process in dielectric spectra. Nevertheless, the presented
scenario requires further investigations to its confirmation. As
mentioned, the larger tendency to form the cyclic H-bonds
between two different molecular species than those between
two IBU molecules in the IBU+acMAL mixtures has been
argued by exploiting our DFT calculations for two isolated
molecules. For example, MD simulations of the binary IBU
+acMAL mixtures would be useful to consider the effect of
surrounding molecules on hydrogen bonding and to perform
such statistical analysis of linear (single) and cyclic (double)
H-bonds that enable the formation of homodimers (IBU···
IBU) and heterodimers (IBU···acMAL), and consequently
evaluate populations of molecular conformations, as it was
carried out by Ottou Abe et al.49 for hydrogen bonding in the
case of pure ibuprofen and pure ketoprofen and their
molecular conformations.
Nonisothermal Crystallization at T > Tg. On the basis of
the dielectric study, we found that both the pure IBU and its
binary mixtures with 5, 10, 20, and 30 wt % of acMAL are not
physically stable and crystallize under nonisothermal con-
ditions during their heating above Tg. As can be seen in Figure
2, the molecular mobility of investigated supercooled binary
systems strongly depends on temperature (see Figure 2).
When the sample is heated, both relaxation peaks (s- and α-)
shift together to higher frequencies, which indicates that the
time scale of molecular motions reflected in both relaxations
Figure 5. Molecular structure of the ibuprofen homodimer (a) and ibuprofen-acMal complex (b). Geometry of structures optimized at the DFT/
B3LYP/Def2-TZVP level of theory.
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becomes shorter with an increase in temperature. It should be
noted that, at some temperature, a sudden drop in the
amplitude of both s- and α-relaxation peaks occurs for all
investigated systems due to a decreasing number of relaxing
dipoles as a result of their immobilization during the
crystallization process. The onset of the rapid decrease in the
amplitude of structural relaxation indicates the beginning of
the drug crystallization. Figure 2 shows that even 30 wt % of
acMAL does not fully suppress IBU against the nonisothermal
crystallization. It is interesting that the crystallization of all
investigated systems occurs at a similar time scale of molecular
mobility reflected in α-relaxation (i.e., τα ∼ 1.5 μs) regardless
of acMAL content in the mixtures. It means that the global
(structural) molecular mobility in the binary mixtures (IBU
+acMAL) at such a characteristic time scale promotes the start
of crystallization under nonisothermal conditions. However, it
is clearly seen that temperatures of onset crystallization
increase with increasing acMAL content, which may suggest
that the physical stability of the systems with larger amounts of
the excipient is improved. Since our binary systems differ in Tg,
to properly estimate the degree of stability improvement of
IBU by acMAL in the supercooled liquid state, we used the
reduced crystallization temperature Tred as the normalized
measure of the tendency to nonisothermal cold crystallization.
The reduced crystallization temperature Tred has been defined
by Zhou et al.52 as the ratio of the temperature range between
crystallization onset and glass transition (Tcrystonset − Tg) to the
temperature range between melting point and glass transition









Tred can take values in the range from 0 to 1 and indicates how
far above Tg the supercooled liquid may be heated before the
cold crystallization occurs. If Tred tends to 1, the system is more
resistant to the cold crystallization under nonisothermal
conditions.
We found that Tred increases with increasing content of
acMAL for IBU+acMAL systems, which indicates that acMAL
gradually improves the physical stability of supercooled IBU in
the binary mixture (see black stars in Figure 6). For
concentrations of acMAL larger than cw > 10 wt %, we
observe a more rapid than linear growth of Tred, which suggests
that the more effective stabilization of IBU begins from this
concentration of acMAL. To assess the degree of the potential
of acMAL to improve the physical stability of various drugs, we
compare dependences of Tred as a function of the content of
acMAL in binary mixtures with several pharmaceuticals: IBU,
celecoxib (CEL), and nifedipine (NIF) (see Figure 6). From
these plots, we evaluated crystallization parameters (CP)
proposed by Bhugra et al.53 within the range of small
concentrations of the acMAL (0−10 wt %) in mixtures for
which the dependences of Tred are linear (see Table 1). The
values of CP (defined as the slopes of the linear fits) suggest
that the potential of acMAL to retard the crystallization of
drugs follows the rank order CEL > NIF > IBU.
Moreover, from Figure 6, it is clearly seen that values of Tred
for the IBU+acMAL mixture (especially for smaller amounts of
the excipient) are significantly smaller than those evaluated for
CEL+acMAL and NIF+acMAL. It means that, among analyzed
systems, the mixtures of IBU+acMAL are characterized by the
weakest physical stability, whereas the mixtures of CEL
+acMAL are the most resistant to the nonisothermal
crystallization (the binary mixture of IBU with concentrations
of acMAL larger than 30 wt % reaches the degree of the
physical stability of pure CEL). The results of the analysis of
Tred for investigated binary mixtures show that acMAL not very
effectively acts as the crystallization inhibitor of IBU under
nonisothermal conditions.
Isothermal Crystallization at T > Tg. In addition to
nonisothermal crystallization investigations, the isothermal
crystallization kinetics study of the pure supercooled IBU
and its mixture with 10 wt % of acMAL at temperatures at
which the systems have the same structural relaxation times,
i.e., τα ≈ 2 μs (see Figure 7a), were also carried out. If we have
two systems which differ in Tg (like it is in the case of pure IBU
and IBU+10 wt % acMAL), the crystallization time τcryst
established for the same time scale of the global molecular
mobility or the same viscosity of these systems seems to be the
most appropriate measure of the tendency to isothermal
crystallization of investigated systems. From the static
dielectric permittivity collected during isothermal crystalliza-
tion of both the systems (IBU and IBU+10 wt % acMAL) at
the same structural relaxation time (see Figures 7b,c), we
evaluated time dependences of the degree of crystallization
(see Figure 7d). The increase in the crystallization degree with
time is expressed by the normalized real permittivity εN′ given
by the following formula:
ε ε ε
ε ε
′ = ′ − ′





(0) ( )N (2)
Figure 6. Reduced crystallization temperature Tred as a function of
acMAL concentration in binary mixtures with different drugs:
ibuprofen (black stars), celecoxib (red points), and nifedipine (blue
points are calculated on the basis of data from ref 21).
Table 1. Values of the Crystallization Parameters CP and
the Coefficients of Determination (R2) for Binary Mixtures
of Different Drugs (CEL, IBU, and NIF) with the Same
Excipient (acMAL)
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where ε′(0) is the static dielectric permittivity at the beginning
of crystallization, ε′(∞) is the long-time limiting value of the
dielectric permittivity, and ε′(t) is the value of the dielectric
permittivity at a given time of crystallization, t.
Figure 7. (a) Dielectric loss spectra for pure IBU and IBU+10 wt % acMAL obtained at temperatures 263 and 269 K, respectively, at which
structural relaxation times for both systems are the same τα = 2 μs. Dielectric spectra of the real part of the complex dielectric permittivity collected
during an isothermal crystallization of (b) pure IBU and (c) IBU+10 wt % acMAL at the same α-relaxation times τα ≈ 2 μs. (d) Time dependence
of normalized real permittivity εN′ for pure IBU and its binary mixture IBU+10 wt % acMAL, obtained during the isothermal storage of these
systems at different temperatures T = 263 K and T = 269 K, but at the same α-relaxation times τα ≈ 2 μs for both of the systems.
Figure 8. Relaxation map obtained at T > Tg for pure IBU and pure acMAL and for their binary mixtures (IBU+acMAL) with different
concentrations of acMAL. Circle and triangle points indicate the dielectric α- and s-relaxation times, respectively, whereas stars denote calorimetric
α-relaxation times evaluated from TMDSC data.
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From the crystallization kinetics curves presented in Figure
7d, we established that the crystallization process for IBU with
10 wt % acMAL is significantly longer than that for the pure
drug. While the two systems have the same structural
molecular mobility in the supercooled liquid state, the
crystallization time of the mixture IBU+10 wt % acMAL is
18 h longer than that for neat IBU, which means that acMAL
stabilizes IBU in the supercooled binary mixtures against the
isothermal crystallization in isochronal conditions.
The enhancement of the physical stability of IBU by acMAL
under isothermal and nonisothermal conditions can be related
to H-bonds formed between IBU and acMAL molecules.
Previous studies suggested that the cyclic H-bonds between
IBU molecules favor the crystallization of the pure drug.49 As
already mentioned, acMAL molecules form stronger H-bonds
with IBU molecules than those between molecules of the drug.
Thus, we can suspect that the population of cyclic H-bonds
between IBU molecules decreases at the expense of an
increasing population of H-bonds between different molecular
species in the binary mixtures (IBU+acMAL). In this way, the
crystallization tendency of IBU is smaller due to the additive of
acMAL.
Molecular Factors Determining Physical Stability at T >
Tg. To obtain the relaxation map for all investigated systems,
reflecting times scales of molecular motions in the wide
temperature range, the complex permittivity ε(ω) of
investigated mixtures has been described by means of the
Havriliak−Negami (HN) formula:54,55
ε ω ε ε ε
ε
ωτ
= ′ − ′′ = + Σ
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where k indicates a relaxation process, Δε is the relaxation
strength, τ is the HN relaxation time, γ and δ represent
symmetric and asymmetric broadening of the loss curve, and
ε∞ is the high-frequency limit permittivity. When δ = 1, the
Cole−Cole (CC) function is generated. It should be noted
that the shape of the s-relaxation peak in the binary mixtures is
symmetrical but broad, and it cannot be described by the
Debye formula (for which δ = 1, γ = 1 in eq 3) like it was for
the D-process in pure IBU. Therefore, dielectric spectra
obtained for mixtures (at T > Tg) were fitted by means of the
superposition of the HN (α-process) and the CC (s-process)
functions. From this analysis of dielectric spectra, the
relaxation maps for investigated systems above their Tg’s
were obtained (see Figure 8)
The temperature dependences of relaxation times for both
the processes (α and s) are nonlinear and have been fitted to











where τ∞, T0, and D are fitting parameters.
As can be seen in Figure 8, both the α- and s-processes
rapidly slow down in the case of all examined systems during
their vitrification. To identify which of them is indeed the
structural relaxation related to the glass transition of the
investigated binary systems, the stochastic temperature-
modulated DSC study (TOPEM) has been performed. From
the temperature and frequency dependences of the complex
heat capacity, the calorimetric relaxation times as a function of
temperature have been determined near Tg (see the star points
in Figure 8). It is clearly seen that the faster process from
dielectric measurements is certainly the structural α-relaxation
of the binary mixtures because dielectric relaxation times of
this process can be successfully extrapolated to the calorimetric
α-relaxation times (calorimetric data lies along the VFT fit
curve extrapolated from the dielectric data).
Antiplasticization. Based on the temperature dependences
of the dielectric α-relaxation times, the values of the glass
transition temperature Tg, defined at τα(Tg) =100 s, were
determined for all examined systems and plotted as a function
of acMAL content in the binary mixtures and compared with
those from DSC experiments. It is worth noting (see Figure 9)
that the values of Tg from different experiments (i.e., dielectric,
TMDSC, and standard DSC measurements) are approximately
the same.
The enhancement of the physical stability of IBU by acMAL
in the supercooled binary mixtures is associated with some
antiplasticization effect of the excipient on IBU, which is the
consequence of the slowdown in the global molecular mobility
of these systems. However, as can be seen in Figure 9, the
increase in Tg of binary mixtures with adding acMAL is much
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where wIBU and wacMAL are the mass fractions of each
component and TgIBU and TgacMAL are their corresponding Tg
values. The constant K in the CK model (eq 5) is related to the
ratio of the change in heat capacity at Tg of the two
components of investigated binary mixtures (K = ΔCpacMAL/
ΔCpIBU). For IBU+acMAL mixtures, the parameter K = 0.90
was determined using values of ΔCp_acMAL = 0.38 J/(gK) and
ΔCp_IBU = 0.42 J/(gK) measured by TOPEM.
The experimental dependence of Tg vs acMAL concen-
tration (blue line in Figure 9) described by the CK equation
with the free fitting parameter K = 0.35 shows a negative
Figure 9. Plot of Tg values of the binary mixtures (IBU+acMAL) from
dielectric and calorimetric measurements as a function of acMAL
concentration. The red line indicates the fit curve of experimental data
to eq 5 with the fixed-parameter K = 0.90 evaluated from DSC data,
whereas the blue line shows the free fit curve of the experimental data
to eq 5 for which the parameter K = 0.35 deviates significantly from
that determined from DSC.
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deviation from the CK prediction (red line in Figure 9) that
assumes an ideal mixing. An analogous pattern of the behavior
of Tg vs content of mixture components for different binary
systems has been thoroughly analyzed by Shamblin et al.60
They have argued that such a deviation from the CK
prediction (due to the experimental Tg values lower than the
expected ones) occurs if the total energy of interactions
between molecules of different molecular species is less than
that between molecules of the same molecular species. In case
of mixtures containing some polymer blends, the authors
considered that the decrease in Tg below the CK curve can be
caused by a net loss in the degree of hydrogen bonding on
mixing, which means the fewer number and/or strength H-
bonds between molecules of different molecular species
relative to the H-bonds between molecules of the same
molecular species. In the case of the investigated binary
mixtures (IBU+acMAL), H-bonds formed between IBU and
acMAL molecules should be stronger than those formed
between two IBU molecules, as we have already discussed
herein based on our DFT calculations. Thus, the negative
deviation from the CK prediction for IBU+acMAL mixtures
may indicate that there are some steric constraints caused by
acMAL molecules in the binary mixtures, which hinder the
formation of H-bonds between IBU molecules, and/or the
strength of H-bonds formed between IBU and acMAL
molecules may slightly weaken, if a molecule of acMAL
accepts a few IBU molecules, whereas the contribution of van
der Waals interactions between acMAL molecules to molecular
dynamics of the binary mixtures increases. It is worth noting
that the number of H-bonds formed between IBU and acMAL
molecules reaches a saturation level at which almost all IBU
molecules are hydrogen bonded by acMAL molecules.
Invoking our DFT calculations, one can assume that the
saturation level for hydrogen bonds in the IBU+acMAL
systems is characterized by three or even four H-bonds
effectively formed by each acMAL with IBU molecules, which
corresponds to the mole fraction of acMAL xw ≈ 0.2. Then, the
increasing acMAL content in the binary mixtures (IBU
+acMAL) results in a gradually dominating role of van der
Waals interactions between acMAL molecules in the systems.
Moreover, from Figure 9, one can see some disadvantages of
IBU+acMAL binary systems from the application point of
view. To obtain the amorphous solid dispersion (ASD) of IBU
+acMAL at room temperature TRT, a large content of acMAL
excipient (more than >85 wt %) is necessary. Binary mixtures
of IBU with smaller content of acMAL than 85 wt % are not
solid at TRT but very viscous liquids. Due to the need to use a
large concentration of acMAL for ASD preparation, acMAL is
not the best candidate that could give a satisfactory
formulation for IBU.
Fragility. Another factor associated with the temperature
dependences of the global molecular mobility and very often
used to predict the physical stability of amorphous systems is














The fragility parameter is closely related to the apparent
activation energy for α-relaxation ΔEa determined at Tg, mp =
ΔEa(Tg)/Tg, where R is the gas constant and ΔEa is defined61
at a constant pressure as follows:
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The fragile liquids are characterized by a higher ratio ΔEa
(Tg)/Tg in comparison with strong materials. The fragility
parameter is a measure of the sensitivity of molecular dynamics
of supercooled liquids to changes in temperature near the glass
transition. In terms of the value of mp, glass-forming liquids are
classified as strong (mp ≤ 30), moderately fragile (30 < mp <
100), and fragile (mp ≥ 100). A large value of mp indicates that
small temperature fluctuations near Tg cause significant
changes in molecular mobility that may lead to stable nuclei
or to attach to a growing crystal face, which is the reason for a
large tendency of material crystallization. Therefore, it is
regarded that more fragile drugs have a larger tendency to
crystallize, whereas the physical stability is better for stronger
liquids (i.e., for smaller values of mp) in both the supercooled
liquid and glassy states. However, there are known exceptions
for this correlation for pure drugs.62−64 Although most drugs
are classified as fragile or moderately fragile, these systems
nevertheless are characterized by a completely different
tendency to crystallization.
Recently, we have tested whether this correlation is fulfilled
for some binary systems. We have found that the better
physical stability correlates with the decrease in the fragility
parameter with increasing content of excipient in a mixture for
CEL+acMAL and CEL+PVP binary systems.20 A similar
correlation has also been reported for the binary mixtures of
indomethacin (IND) with acMAL22 (see Figure 10a).
In the case of the IBU+acMAL binary mixtures examined
here, we have established the opposite correlation of fragility
with the physical stability of the systems. As can be seen in
Figure 10a, the fragility parameter for IBU+acMAL signifi-
cantly increases with increasing content of the excipient in the
mixture despite the increasing improvement of IBU stability in
the binary systems. It is worth noting that Kaminska and co-
workers also found such an opposite correlation for binary
mixtures of nifedipine with several acetylated saccharides.21
This indicates that the fragility parameter does not always
correctly predict the stability of amorphous drugs. Thus, we
cannot recommend the use of the fragility parameter to predict
the tendency of drugs to crystallization.
Activation Energy of α-Relaxation. In addition to the
fragility parameter, the activation energy is one of the most
fundamental characteristics of structural relaxation and glass
transition. Therefore, we checked whether the activation
energy Ea of the α-relaxation determined at Tg of IBU
+acMAL and CEL+acMAL binary mixtures also exhibits
different patterns of behavior as a function of the molar
fraction of the excipient (see Figure 10b). Molecular
rearrangements reflected in structural relaxation need some
amount of activation energy Ea to overcome the thermody-
namic potential barriers. Thus, this dynamic factor can be
helpful in the study of the physical stability of amorphous
drugs. As can be seen in Figure 10b, the dependences of the
activation energy for IBU+acMAL and CEL+acMAL vs the
molar fraction xw of acMAL reveal a similar pattern of behavior
as we found for mp. It is very interesting that the dependence
for IBU+acMAL monotonically increases from very small
values of Ea with increasing content of acMAL, whereas the
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function of Ea (xw) for CEL+acMAL is nonmonotonic
(initially, the addition of acMAL to CEL results in a decrease
in Ea of the binary mixture, whereas the values of Ea become
increasing for xw > 0.2). The values of Ea for pure drugs (IBU
and CEL) differ significantly (by around 300 kJ/mol), but they
converge and become nearly the same for xw > 0.2. These
findings for mp and Ea are intriguing because molecular
interactions in both the binary systems are similar: molecules
of pure drugs can form H-bonds (IBU···IBU and CEL···CEL),
as well as molecules of drugs, and may form H-bonds with the
excipient molecules (IBU···acMAL and CEL···acMAL), where-
as only van der Waals interactions are relevant between
molecules of acMAL. It indicates that H-bonded supra-
molecular structures are different in both the binary systems,
which influences their global molecular dynamics. We have
also observed that the dependences of the activation energy Ea
at Tg on the acMAL content in the binary mixtures correlate
with the plasticization/antiplasticization effects of the excipient
on the drugs (IBU and CEL). Small amounts of acMAL
plasticize CEL (see the upper inset in Figure 10b); that is, the
molecular mobility reflected in the structural relaxation of the
CEL+acMAL mixture at Tg increases, which corresponds to
the decrease in Ea of the global relaxation. On the contrary,
above 30 wt % of acMAL in the CEL+acMAL mixture, the
antiplasticization effect is observed; that is, the structural
molecular mobility begins to grow, which is correlated with the
increase in Ea at Tg. However, in the case of the IBU+acMAL
binary system, acMAL exerts only an antiplasticization effect
on IBU for any content of the excipient (see the lower inset in
Figure 10b), which is reflected in the monotonic growth of Ea
with adding acMAL to IBU.
Dynamic Heterogeneity. One of the fundamental problems
is how different kinds of molecular interactions affect the
dynamic heterogeneity of the global molecular dynamics of the
supercooled liquids and, consequently, their physical stability?
The concept of dynamic heterogeneity has been firmly
established in the glass transition physics since 1965, when the
Adam−Gibbs model was formulated.65 Within this model, the
molecular mobility near the glass transition is characterized by
correlated motions of neighboring molecules, which results in
the appearance of cooperatively rearranging regions (CRR)
defined as a subsystem that can rearrange into another
configuration independently of its environment upon a
sufficient thermal fluctuation.66 Hence, the rapid slowdown
in molecular dynamics observed near the glass transition has
been attributed to an increasing size of CRRs, reflecting that
the molecular dynamics of a supercooled liquid becomes more
and more heterogeneous in both time and space domains
when approaching the glass transition. The experimental and
evaluation ways to find a characteristic number of dynamically
correlated molecules Nα, which determines the characteristic
size of dynamic heterogeneity, are still debated.67 Since direct
measurements of Nα are very difficult, various estimates are
applied to quantify Nα. Among them, the commonly used ones
are the estimates based on the fluctuation−dissipation
theorem, which have been proposed separately for the entropy
fluctuations by Donth68,69 and the enthalpy fluctuations by
Berthier et al.70 In contrast to the latter, the Donth estimate
requires experimental data collected only by using a single
measurement technique that provides a temperature depend-
ence of the specific heat capacity Cp measured within the
temperature range in which the glass transition occurs. The
width of the step in the temperature dependence Cp(T) at the
Figure 10. Dependences of acMAL mole fraction on different
molecular factors for binary mixtures (drug+acMAL): (a) isobaric
fragilities (data for binary mixtures indomethacin (IND), nifedipine
(NIF), and celecoxib (CEL) with acMAL were taken from refs 22, 21,
and 10, respectively), (b) activation energy Ea of dielectric α-
relaxation at Tg of the binary systems (the inset shows glass transition
temperatures for IBU+acMAL and CEL+acMAL as a function of
weight concentration of acMAL), (c) numbers of dynamically
correlated molecules Nα at Tg evaluated from Donth model (eq 8)
based on temperature dependences of the heat capacity Cp of
investigated systems showed in the inset, (d) the change in the heat
capacity ΔCp at Tg of investigated systems of IBU+acMAL derived
from data showed in the inset of panel c.
Molecular Pharmaceutics pubs.acs.org/molecularpharmaceutics Article
https://dx.doi.org/10.1021/acs.molpharmaceut.0c00517
Mol. Pharmaceutics 2020, 17, 3087−3105
3097
glass transition has been related to the size of temperature
fluctuations.71 Consequently, the number of dynamically
correlated particles, Nα(Tg), or the corresponding volume of
the area occupied by the dynamically correlated molecules,


























where Tg is the glass transition temperature, ρ is the material
density, kB is the Boltzmann constant, M is the molar mass,
Cp
glass and Cp
liquid are the isobaric heat capacities of glass and
liquid at Tg, and δT is the average temperature fluctuation,
which is related to the dynamic glass transition. The Donth
formula was originally derived68 in the NVT statistical
ensemble. However, eq 8 is its representation in the NPT
statistical ensemble,72 which is suitable to use in typical
experimental conditions.
We have applied the Donth model to determine the number
of dynamically correlated molecules at Tg, exploiting the results
of TOPEM measurements for pure compounds (IBU, CEL,
and acMAL) and for investigated binary systems (IBU+acMAL
and CEL+acMAL) with different content of acMAL. To our
best knowledge, such analyses of the dynamic heterogeneity
have not been made in mixtures until now. As can be seen in
Figure 10c, in contrast to the activation energy and fragility of
the binary systems (IBU+acMAL and CEL+acMAL), the
number of dynamically correlated molecules Nα rapidly
decreases with increasing acMAL content in the entire range
of acMAL mole fraction xw.
The dramatic decreasing dependences Nα(xw) reflect the
already discussed changes in the character of molecular
interactions from H-bonded to van der Waals systems when
adding acMAL to both the drugs. The numbers of dynamically
correlated molecules drop from the largest values for H-
bonded pure drugs to the smallest one for acMAL interacting
via van der Waals forces. It should be noted that Nα for IBU is
larger than that for pure CEL (195 and 105 molecules,
respectively). It is probably related to the more complex H-
bonding rearrangements in the case of pure IBU compared to
pure CEL or/and the stronger H bonds formed between IBU
molecules than those between CEL molecules (as established
from our DFT calculations performed herein for IBU systems
and previously for CEL systems).10 All findings depicted in
Figure 10c seem to be significant to the glass transition physics
because they suggest that there is a correlation between Nα and
changes in the H-bonded supramolecular structures in the
system, which requires, however, further investigations of other
H-bonded systems to verify whether it is a rule or not. This
issue is very interesting, especially since a similar rapid decrease
in Nα due to the changing character of intermolecular
interactions from supercooled liquids dominated by dipole−
dipole interactions to their counterparts dominated by ionic
interactions has been recently established from the compara-
tive analysis of selected drugs formed as bases and their protic
ionic counterparts.73
It should be emphasized that the Donth method enables the
evaluation of the dynamic property Nα only based on
thermodynamic parameters (eq 8). One of them is the jump
in the heat capacity ΔCp at Tg, which reflects a change in
molecular mobility during the glass transition. It is interesting
that ΔCp rapidly decreases when adding acMAL to IBU
similarly to Nα (see Figure 10d). It suggests that the change of
some molecular motions related to the jump of the heat
capacity ΔCp during the glass transition is larger for systems
with H-bonded supramolecular structures than that for van der
Waals glass-forming liquids.
It is very tempting to find a correlation between Nα and the
tendency to crystallization. Such attempts have been earlier
made for some simulation models74−76 and a few neat
drugs.77,78 For neat sildenafil, it has been found that the
improvement of physical stability is correlated with an increase
in Nα. In the case of the compared binary systems (IBU
+acMAL and CEL+acMAL), we obtained the opposite
dependence; i.e., Nα, as well as the tendency to crystallization,
decreases when adding acMAL to the drugs (in the range 0 <
xw < 0.2). Although it has been suggested that a net loss in
hydrogen bonding occurs when adding acMAL to the mixtures,
which seems to be revealed in the drop in Nα, we need to
remember that the population of H-bonded heteroclusters
(IBU···acMAL, and CEL···acMAL) increases at the expense of
H-bonded homoclusters of medicines (IBU···IBU and CEL···
CEL) up to a saturation level at which almost all drug
molecules are hydrogen bonded by acMAL molecules (at xw ≈
0.2). The formation of such H-bonded supramolecular
heterostructures is considered in both the binary mixtures
IBU+acMAL and CEL+acMAL as a molecular mechanism,
improving the physical stability of the systems. However, Nα
reflects the average dynamic heterogeneity of a binary mixture
coming from H-bonded homoclusters, H-bonded hetero-
clusters, and van der Waals interactions. Thus, we are not
able to distinguish the contribution to the dynamic
heterogeneity coming from only such H-bonded hetero-
structures, improving the physical stability of the drugs in
the binary mixtures with acMAL. Nevertheless, we can suppose
that the population of H-bonded heteroclusters, which
increases relative to the population of H-bonded homoclusters
(with increasing content of acMAL in the range 0 < xw < 0.2),
should result in a relative increase in the number of
dynamically correlated molecules involved in the H-bonded
heteroclusters, and this increase could be relevant to the
improvement of the physical stability of the binary mixtures.
Relaxation Processes at T < Tg. It has been often
considered that local molecular motions reflected in secondary
relaxations can be responsible for nucleation and consequently
crystallization of drugs in the glassy state.16,79,80 The secondary
processes are typically classified into Johari−Goldstein (JG)
and non-JG relaxations. The JG relaxation has a local
intermolecular character (small-angle rotations of entire
molecules) and is regarded as a precursor of the molecular
mobility of the cooperative α-relaxation, whereas non-JG
relaxations reflect some intramolecular motions of some parts
of molecules.81 Secondary relaxations of pure IBU have already
been thoroughly analyzed both under ambient and elevated
pressure.48,47 It has been found that pure IBU exhibits two
secondary relaxations (β and γ). The fast γ-process of pure IBU
is insensitive to pressure changes, and it was classified as an
intramolecular non-JG relaxation.48 Whereas the slower β-
relaxation has been assessed as the local intermolecular JG
process based on the Coupling Model analysis,47 which has
been later confirmed by finding its sensitivity to pressure
changes.48 However, pure acMAL exhibits only one secondary
relaxation, called the μ-process, which originates from the
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intramolecular rotations of the acetyl moiety (C−O−
(COCH3)) in the acMAL molecule.
10
As can be seen in Figure 11a, the μ-process of pure acMAL
and the β-process of pure IBU are observed within the same
frequency range, but the μ-process of the excipients has a
considerably larger magnitude than the β-relaxation of the
drug. Consequently, when acMAL is added to IBU, we observe
a significant increase in the contribution of the μ-process to
dielectric spectra of the binary mixtures. The magnitude of the
(βμ)-process in the binary mixtures, which is a superposition
of β- and μ-processes of the pure compounds, increases with
an increasing amount of acMAL in the mixture. It indicates
that the molecular dynamics of mixtures in the glassy state is
gradually dominated by acMAL. Nevertheless, the significant
increase in the dielectric strength of the (βμ)-process is
accompanied by only a slight slowdown in the relaxation and a
small decrease in its activation energy when adding acMAL to
the drug (see Figure 11b in which dielectric loss spectra are
shown at T = 218 K as a representative example and Table 2).
Therefore, the molecular motions reflected in the JG relaxation
do not seem to influence the physical stability of the IBU
+acMAL binary mixtures.
Analyzing the non-JG γ-process in IBU, we have found that
its dielectric strength is nearly invariable when adding acMAL
to the drug. The insensitivity of the γ-relaxation to acMAL is
also represented by the same values of the activation energy
and relaxation times for the γ-process in pure IBU and its
binary mixtures with acMAL (see Figure 11b and Table 2).
Thus, we should exclude any role of the γ-relaxation in the
enhancement of the physical stability of IBU by mixing with
acMAL. To find the origin of the intramolecular dielectric γ-
process in IBU, we have performed DFT calculations for the
drug molecule. In the DFT simulation, we have considered
four different intramolecular rotations in the IBU molecule:
Ph−C2H4COOH (Φ1), Ph−CH2C3H7 (Φ2), PhC2H4−
COOH (Φ3), PhCH2−C3H7 (Φ4) presented in Figure 12a.
The energy and dipole moment changes of IBU molecule as a
function of rotation angles Φ1, Φ2, Φ3, and Φ4 are shown in
Figure 12b−e, respectively. On the basis of the DFT analyses,
we have established that the rotation around the axis PhCH2−
C3H7 with respect to the angle Φ4 has the highest activation
energy (ΔE = 21 kJ/mol) among all the examined intra-
molecular rotations. This value is close to the activation energy
(ΔEγ = 26 kJ/mol) of the γ-relaxation, which suggests that the
secondary dielectric process originates from the PhCH2−C3H7
reorientations. It is worth noting that the rotation PhCH2−
C3H7 reflected in the γ-relaxation (not involved in improving
the physical stability of IBU) cannot be affected by hydrogen
bonding. It reinforces our previous consideration of the
important role of H-bonds dynamics in reducing the tendency
of IBU to crystallization in the binary systems with acMAL.
■ WATER SOLUBILITY AND DISSOLUTION RATE
STUDY
Finally, we studied the water solubility and the dissolution rate
of IBU in the binary systems with large amounts of acMAL,
which are amorphous solid dispersions (ASDs) in normal
conditions. The solubility of the drug was tested in distilled
water at room temperature. The equilibrium solubilities have
been measured after 48 h. We found that although acMAL
improves the physical stability of amorphous IBU in the binary
mixtures, it does not significantly improve the solubility of the
drug in water from the ASDs. The equilibrium water solubility
of IBU from ASD with the large contents of acMAL (IBU+83
wt % acMAL, IBU+86 wt % acMAL, and IBU+87.5 wt %
acMAL) is only ∼10% higher in comparison with the water
solubility of the pure crystalline IBU (see Figure 13). It should
be noted that the IBU mixtures with small acMAL content,
Figure 11. (a) Comparison of dielectric spectra for pure IBU, acMAL, and binary mixtures of IBU with acMAL obtained in the glassy state of
investigated systems at the same temperature (218 K) at which secondary relaxations are observed. (b) Temperature dependences of structural (α)
and secondary (β, (βμ), μ, and γ) relaxations times for pure IBU, acMAL, and binary mixtures of IBU with acMAL.
Table 2. Values of the Activation Energy of Secondary
Relaxations Observed in Pure IBU, acMAL, and Binary
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which are supercooled viscous liquid at room temperature,
immediately recrystallized during the contact with water.
Additionally, we analyzed the dissolution profiles of IBU
from ASD with the large contents of acMAL (i.e., for IBU+83
wt % acMAL, IBU+86 wt % acMAL, and IBU+87.5 wt %
acMAL) in the water at a human body temperature (37 °C).
We observed that the dissolution rate of pure crystalline IBU is
much higher than that for ASD with acMAL. It indicates that
acMAL negatively affects IBU, significantly retarding the rate
of release of the drug from ASD (Figure 14).
These results are interesting because there are several
examples of drugs (e.g., celecoxib10 and indomethacine22) for
which the water solubility considerably is improved by acMAL
in ASD. However, these drugs are characterized by much
higher values of Tg than that of IBU, and consequently, the
values of Tg of their ASDs with acMAL are higher than 40 °C.
Whereas in the case of ASD of IBU with acMAL, despite the
huge content of acetylmaltose in the ASDs, the values of Tg of
the binary mixtures of IBU with acMAL are very low, close to
room temperature (see Figure 9). The poor dissolution rate of
the ASD of IBU with acMAL is probably associated with the
Figure 12. (a) Molecular structure of ibuprofen monomer. Geometry of structures optimized at the DFT/B3LYP/Def2-TZVP level of theory.
Rotation coordinates are depicted: Φ1, Φ2, Φ3, and Φ4. (b−e) Energy (black line) and dipole moment changes (red line) of ibuprofen molecule as
a function of rotation angle Φ1, Φ2, Φ3, and Φ4, respectively.
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fact that the temperature of the dissolution medium (i.e.,
water) was higher (like the temperature of the human body)
than Tg of all of the tested systems. Consequently, the binary
mixtures (IBU+acMAL) at a human body temperature become
rubbery and stuck into agglomerates of limited surface area,
reducing their dissolution rate in water. Therefore, we
recommend formulating the ASDs of much higher Tg than
the temperature of the human body (ca. 37 °C) to avoid some
agglomerations of sticky particles prior to starting dissolution.
■ CONCLUSIONS
Two dielectric processes (i.e., the slow s-relaxation and α-
structural relaxation) have been observed above Tg of the
binary mixtures IBU+acMAL. Nevertheless, our study has not
confirmed any inhomogeneity and microphase separation of
the investigated binary systems. The amplitude of the s-process
increases rapidly with increasing content of acMAL in the
mixture in a much more intensive manner than the α-structural
relaxation peak. After considering the dielectric behavior of the
s-process, our DFT calculations, and earlier published reports
on neat IBU, we suppose that the origin of s-process may come
from the synperiplanar to the antiperiplanar transformation of
carboxyl groups in IBU molecules, which is possibly promoted
by heterocyclic H-bonds between IBU and acMAL molecules,
but this scenario requires further investigations to its
confirmation.
Based on isothermal and nonisothermal crystallization
investigations, we have found that acMAL improves the
physical stability of supercooled IBU, which has a big tendency
to crystallize above Tg as a pure compound. However, we have
evaluated that the stabilization effectiveness of acMAL is less
for IBU than that for celecoxib or nifedipine. The enhance-
ment of physical stability of IBU in the binary systems with
acMAL is due to interplaying mainly two factors: specific
intermolecular interactions between IBU and acMAL by strong
H-bonds and some antiplasticization effect of acMAL on IBU.
Heteroclusters formed by IBU and acMAL molecules through
H-bonds hinder the formation of double H-bonds between
IBU molecules and consequently prevent the drug crystal-
lization. The glass transition temperature Tg of the binary
mixtures increases with adding acMAL. However, this
antiplasticization effect, related to the slowdown in the global
molecular mobility, is much weaker than that predicted by the
Couchman−Karasz equation. It can affect stabilization
effectiveness. The negative deviation of the experimental
dependence of Tg on the content of acMAL from the CK
prediction can be caused by a net loss of hydrogen bonding,
suspected in the tested binary systems when adding this
excipient.
We have also examined other important parameters often
considered as molecular factors of the tendency to
crystallization such as the fragility parameter mp, the activation
energy for structural relaxation Ea, and the average number of
dynamically correlated molecules, quantifying the dynamic
heterogeneity of the investigated systems, Nα. The thorough
analyses of the parameters mp, Ea, and Nα, evaluated at the glass
transition temperatures of the binary mixtures of IBU with
acMAL have enabled us to formulate a few observations on the
utility of these parameters to predict the physical stability of
the binary pharmaceutical systems with acMAL. (i) We have
established that the fragility parameter inversely correlates with
the crystallization tendency of the IBU+acMAL binary
mixtures, which is opposite to the expected correlation.
Thus, we cannot recommend the fragility to use as a universal
parameter to predict the tendency of drugs to crystallization.
(ii) The dependence of the activation energy Ea for structural
relaxation at Tg on the content of acMAL in the binary
mixtures is qualitatively the same as that for mp and exhibit
different monotonicities for two kinds of binary systems (IBU
+acMAL) and (CEL+acMAL). For these reasons, none of
these parameters can be exploited separately as a reliable factor
of the physical stability of the amorphous pharmaceutical
systems. However, we have found that the changes in mp and
Ea correlate with the plasticization/antiplasticization effects of
acMAL on the drugs (IBU and CEL). (iii) Only the
dependence of the dynamically correlated molecules Nα on
the content of acMAL xw has the same monotonicity in both
kinds of binary mixtures (IBU+acMAL) and (CEL+acMAL).
The decreasing dependences Nα(xw) can be caused by changes
in the character of intermolecular interactions in these binary
systems with increasing acMAL content, which transform the
initially strongly H-bonded supramolecular structures to the
systems dominated by van der Waals interactions. This finding
seems to be significant to the glass transition physics and
requires further verifications by studying other H-bonded
systems. However, a straightforward correlation between the
Figure 13. Equilibrium water solubilities of the pure crystalline IBU
and amorphous IBU in ASDs with large contents of acMAL (i.e., for
IBU+83 wt % acMAL, IBU+86 wt % acMAL, and IBU+87.5 wt %
acMAL) at room temperature.
Figure 14. Dissolution profiles in water for the pure crystalline IBU
and amorphous IBU from ASDs with various amounts of acMAL at
37 °C.
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physical stability and the dynamic heterogeneity quantified by
Nα cannot be established because the estimate of Nα reflects
the average dynamic heterogeneity of the binary mixture
coming from H-bonded homoclusters (API···API), H-bonded
heteroclusters (API···acMAL), and van der Waals interactions,
whereas the improvement of the drug physical stability by
acMAL is mainly associated with the formation of hetero-
clusters (API···acMAL).
Comparing the secondary relaxation processes in pure IBU
and its binary mixtures with acMAL in the glassy state, we have
found that the activation energy and the relaxation times of the
JG process only slightly vary when adding acMAL to the drug,
and these quantities are even invariant in the case of the non-
JG relaxation. Thus, the molecular motions reflected in the JG
(βμ)- and non-JG γ-processes observed in the glassy state of
the IBU+acMAL mixtures do not seem to influence the
physical stability of these binary systems.
Our study of the water solubility as well as the dissolution
rate of IBU in the binary systems with a large amount of
acMAL, which form amorphous solid dispersions (ASDs) in
normal conditions, has revealed that acMAL unfavorably
affects these properties of IBU. The water solubility of such
ASDs at room temperature is slightly improved compared to
pure crystalline IBU, and acMAL significantly retards the
release rate of the drug from ASDs at human body
temperatures. The latter negative effect is most probably
caused by forming some agglomerations of sticky particles
prior to starting dissolution. To avoid such inconveniences, we
may recommend that Tg of ASDs should be much higher than
the human body temperature.
Our research shows that acMAL is not a universal excipient
for any amorphous API that improves its properties. The
binary compositions of IBU and acMAL examined herein in
the supercooled liquid and glassy states are the first examples
of the application of acMAL to stabilize the ASDs, which are
not recommended to use due to their poor water solubility and
dissolution rate as well as relatively small stabilization
effectiveness. Nevertheless, this case provides us with valuable
advice on how one should combine drugs and their
crystallization inhibitors to prepare physically stable ASDs
characterized by a better water solubility and dissolution rate in
the therapeutically relevant temperature range.
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